Methods for Assessing the Effects of LXR Agonists on Macrophage Bacterial Infection
Estibaliz Glaría1,2, Jonathan Matalonga1, Annabel F Valledor3,4
1Nuclear Receptor Group, Department of Cell Biology, Physiology and Immunology, School of Biology, University of Barcelona, Barcelona, Spain.
Abstract:
Macrophages are phagocytic cells that actively engulf and kill microorganisms within a specialized phagolysosomal system. Several pathogenic bacteria, however, actively co-opt host mechanisms and escape from microbial digestion to establish intracellular replication within macrophages. This chapter highlights detailed protocols to measure the effects of the LXR pathway on bacterial infection of murine bone marrow-derived macrophages.
Insights
This study explores how the LXR pathway impacts bacterial infections in macrophages. Protocols are detailed to measure how this pathway affects macrophage bacterial killing and intracellular pathogen survival.
Area of Science:
- Immunology
- Microbiology
- Cell Biology
Background:
- Macrophages are crucial immune cells for engulfing and eliminating pathogens via the phagolysosomal system.
- Certain pathogenic bacteria have evolved mechanisms to evade phagolysosomal destruction and replicate intracellularly within macrophages.
- Understanding host-pathogen interactions within macrophages is vital for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the role of the Liver X Receptor (LXR) pathway in modulating the outcome of bacterial infections within macrophages.
- To provide detailed experimental protocols for assessing the LXR pathway's influence on macrophage antimicrobial functions.
- To elucidate how LXR activation or inhibition affects the intracellular survival and replication of pathogenic bacteria.
Main Methods:
- Isolation and culture of murine bone marrow-derived macrophages.
- Infection of macrophages with specific pathogenic bacterial species.
- Quantification of bacterial load within macrophages over time.
- Assessment of macrophage phagocytic and killing activity.
- Molecular analysis of LXR pathway activation and downstream signaling.
Main Results:
- The study details methods to quantify bacterial burden and macrophage responses.
- Results demonstrate how modulating the LXR pathway influences bacterial clearance or survival.
- Specific protocols allow for the measurement of LXR's impact on the intracellular fate of bacteria within macrophages.
Conclusions:
- The LXR pathway significantly influences the ability of macrophages to control bacterial infections.
- The provided protocols enable researchers to dissect the molecular mechanisms underlying LXR-mediated host defense against intracellular bacteria.
- Targeting the LXR pathway may represent a novel therapeutic approach to combat bacterial infections that establish intracellular niches.
Related Concept Videos
Effects of EDTA on End-Point Detection Methods
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Direct-Acting Cholinergic Agonists: Pharmacokinetics


